A all-Italian research is developing a new capable biomedical technology, through nanoparticles, of deliver pharmacological therapies aimed at interrupting neurodegeneration. The research team involved comes fromUniversity of Milan.
Scientists were able to take advantage of a research project that includes a funding under the Seed4Innovation scouting program, promoted by the UNIMI Foundation in collaboration with the University’s Innovation and Knowledge Enhancement Department.
Read Also
- Covid, Pregliasco: ‘Interesting data on lactoferrin from in vitro study’ Sep 20, 2021
- Renewable energy: Renault signs huge solar electricity contract with Voltalia Nov 24, 2022
- Scientists found a danger on the far side of the Moon: “We are not made to resist space radiation” Sep 28, 2020
- Biodiversity: ‘Cascade’ of extinctions threaten animals and plants Dec 17, 2022
- The first edition of the Gaceta Médica RD magazine: a novel scientific-medical space May 23, 2022
- They develop an AI capable of writing programming code from natural language May 29, 2021
- Tumors, that’s why they can resist treatment: the study Aug 5, 2021
